Correspondence 0001193125-24-223652 from BioAge Labs, Inc. (BIOA) (CIK 0001709941) (BIOA)
BioAge Labs, Inc. (BIOA) (CIK 0001709941)
Date: Sept. 23, 2024 · CIK: 0001709941 · Accession: 0001193125-24-223652
AI Filing Summary & Sentiment
File numbers found in text: 001-42279, 333-281901
Letter
BioAge Labs, Inc.
1445A South 50th Street
Richmond, California 94804
September 23, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention:
Eric Atallah
Vanessa Robertson
Jimmy McNamara
Joshua Gorsky
Re:
BioAge Labs, Inc. Registration Statement on Form S-1 (File No. 333-281901) originally filed September 3, 2024, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-42279) filed September 18, 2024
Requested Date: September 25, 2024
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
BioAge Labs, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Julia Forbess or Robert A. Freedman, each of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Forbess at (415) 875-2420 or, in her absence, Mr. Freedman at (206) 389-4524.
Sincerely,
BIOAGE LABS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP BioAge Labs, Inc. 1445A South 50th Street Richmond, California 94804 September 23, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Eric Atallah Vanessa Robertson Jimmy McNamara Joshua Gorsky Re: BioAge Labs, Inc. Registration Statement on Form S-1 (File No. 333-281901) originally filed September 3, 2024, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-42279) filed September 18, 2024 Requested Date: September 25, 2024 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: BioAge Labs, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Registrant hereby authorizes Julia Forbess or Robert A. Freedman, each of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Forbess at (415) 875-2420 or, in her absence, Mr. Freedman at (206) 389-4524. Sincerely, BIOAGE LABS, INC. By: /s/ Kristen Fortney Kristen Fortney, Ph.D. Chief Executive Officer cc: Robert A. Freedman, Esq. Matthew Rossiter, Esq. Julia Forbess, Esq. Michael Pilo, Esq. Fenwick & West LLP